This paper is in the following e-collection/theme issue:

Non-randomized Protocols and Methods (ehealth) (567)

Published on in Vol 8, No 4 (2019): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/12144, first published .
Evaluation of Clinical Outcomes and Simultaneous Digital Tracking of Daily Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Protocol for the Observational VENTASTEP Study

Evaluation of Clinical Outcomes and Simultaneous Digital Tracking of Daily Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Protocol for the Observational VENTASTEP Study

Evaluation of Clinical Outcomes and Simultaneous Digital Tracking of Daily Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Protocol for the Observational VENTASTEP Study

Authors of this article:

Christian Mueller1 Author Orcid Image ;   Barbara Stollfuss1 Author Orcid Image ;   Alexander Roitenberg1 Author Orcid Image ;   Jonas Harder2 Author Orcid Image ;   Manuel J Richter3 Author Orcid Image
Article Authors Cited by (4) Tweetations (7) Metrics

Christian Mueller   1 , PhD ;   Barbara Stollfuss   1 , MD, PhD ;   Alexander Roitenberg   1 , MD ;   Jonas Harder   2 , MD, PhD ;   Manuel J Richter   3 , MD

1 Bayer Vital GmbH, Leverkusen, Germany

2 xbird GmbH, Berlin, Germany

3 Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center, Member of the German Center for Lung Research (DZL), Giessen, Germany

Corresponding Author:

  • Christian Mueller, PhD
  • Bayer Vital GmbH
  • Pharmaceuticals Medicine, Pharmaceuticals, Data Generation
  • Building K 56, 1D321
  • Leverkusen, 51368
  • Germany
  • Phone: 49 214-30-46587
  • Fax: 49 214-86486926
  • Email: christian.mueller4@bayer.com